CEFEPIME
Generic: CEFEPIME HYDROCHLORIDE, CEFEPIME
Sagent PharmaceuticalsManufacturer
INTRAMUSCULAR, INTRAVENOUSRoute
CEFEPIME HYDROCHLORIDEActive Substance
2008-03-20Original Approval
CEFEPIME is FDA application ANDA065441, sponsored by ACS DOBFAR. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class I2013-10-15
Cefepime for Injection USP and Dextrose Injection USP, in Duplex Drug Delivery System, 1 g in 50 mL duplex container, FoPresence of Particulate Matter: The 1g Cefepime for Injection USP and Dextrose Injection USP lot ha
Class I2013-11-21
Cefepime for Injections USP and Dextrose Injection USP, 1 g in Duplex, 50 mL Container, Catalog Number 3193-11, For IV UPresence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due t
Top Reported Reactions
1
DRUG INEFFECTIVE
1,605 reports
2
ACUTE KIDNEY INJURY
1,289 reports
3
OFF LABEL USE
1,233 reports
4
PYREXIA
1,110 reports
5
FEBRILE NEUTROPENIA
887 reports
6
PNEUMONIA
826 reports
7
SEPSIS
619 reports
8
HYPOTENSION
601 reports
9
ENCEPHALOPATHY
568 reports
10
NEUTROPENIA
558 reports